
Opinion|Videos|August 6, 2024
Therapies Beyond BCG: FDA-Approved and Emerging Options
Experts discuss available therapies beyond BCG.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- For patients who are either unable to receive BCG therapy, or BCG unresponsive, what other therapeutic options are currently available?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD
4
Microbial dysbiosis may predict response to CBM588 in mRCC
5














